Skip to main content


Figure 3 | BMC Research Notes

Figure 3

From: Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study

Figure 3

Baseline of serum LDL-c of phase 1 and phase 2 of each group. Baseline 1, baseline LDL-c level before the start of active treatments in phase 1; baseline 2 LDL-c level after the washout period; Group 1, pravastatin then combination; Group 2, combination then pravastatin; Group 3, phytosterols then combination; Group 4, combination then phytosterols.

Back to article page